GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » Loans Receivable

Mediera (ROCO:5398) Loans Receivable : NT$0.0 Mil (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Mediera Loans Receivable?

Mediera's Loans Receivable for the quarter that ended in Mar. 2025 was NT$0.0 Mil.


Mediera Loans Receivable Historical Data

The historical data trend for Mediera's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediera Loans Receivable Chart

Mediera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mediera Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mediera Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Mediera Loans Receivable Related Terms

Thank you for viewing the detailed overview of Mediera's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediera Business Description

Traded in Other Exchanges
N/A
Address
No. 239 Datong Road, Section 1, 16th Floor, Xizhi District, New Taipei, TWN
Mediera Corp is engaged in domestic research and development, production and manufacturing of various power supply components, and launched its own brand. MEDIERA is also committed to the production of customized products and OEM. It has been more active in the transformation and layout of the development of medical biotechnology. For example, medicines, healthy foods, and medical equipment that greatly help human health have become the focus of development in recent years. In addition, combined with the scientific and technological research and development capabilities of the Electronics Division, advanced The application of electronic micro-control patented technology in electronic medical equipment that can help patients improve their quality of life is a major breakthrough for company.

Mediera Headlines

No Headlines